Emerging nanoparticle platforms for CpG oligonucleotide delivery
- 16 January 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (9) , 2203-2228
Abstract
In this review, we provide a comprehensive summary of the nanoparticle-based CpG delivery systems developed to improve the efficacy of CpG-mediated immune responses.Keywords
Funding Information
- National Basic Research Program of China (2019YFA0111300)
- National Natural Science Foundation of China (22277155, 52373166)
- Pearl River S and T Nova Program of Guangzhou Municipality (2019QN01Y131)
- Recruitment Program of Global Experts
- China Primary Health Care Foundation (2022-003)
- Guangzhou Municipal Science and Technology Program key projects (2024A04J6572)
This publication has 246 references indexed in Scilit:
- Akt signaling-associated metabolic effects of dietary gold nanoparticles in DrosophilaScientific Reports, 2012
- The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotidesBiomaterials, 2011
- Innovative strategies for co-delivering antigens and CpG oligonucleotidesAdvanced Drug Delivery Reviews, 2009
- CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategiesAdvanced Drug Delivery Reviews, 2009
- Double-stranded RNA- and CpG DNA-induced immune responses in Atlantic salmon: Comparison and synergiesVaccine, 2008
- Engineering cartilage tissueAdvanced Drug Delivery Reviews, 2008
- Ligand-induced conformational changes allosterically activate Toll-like receptor 9Nature Immunology, 2007
- IRF family proteins and type I interferon induction in dendritic cellsCell Research, 2006
- Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNANature Immunology, 2005
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004